• Home
  • Company

  • Notice: Undefined variable: id in /var/www/vhosts/fresenius-kabi-oncology.com/httpdocs/static.php on line 32

Company

Research and Development

The Research & Development (R&D) center at Fresenius Kabi Oncology Limited operates out of a highly modern facility based in Gurgaon, India and is engaged in developing next generation cytotoxic, cytostatic and targeted therapies. It delivers high quality, and cost-effective products using cutting-edge technology by maintaining highest standard of quality for all its products irrespective of the target market. The R&D Centre is fully equipped to develop oncology products through its modern synthetic organic chemistry laboratories, which have the capabilities to handle wide range of chemistries. It develops non-infringing, safe and cost-effective processes which are scalable to plant level with minimum rework.

The Company has broadest portfolios of oncology generic products with focus on "First to Market" opportunities. The innovative product portfolio is a testimony to the Company’s capability in Research and Development.  The Project Management based approach in the product development sector ensures streamlined process and delivery.

The R&D capability at Fresenius Kabi Oncology Limited focuses on core clinical innovation, management of the various levels of drug development right from the pre-clinical studies, managing clinical trials etc. It also looks into the development and validation of methods for new product development, product stability monitoring and supporting manufacturing processes all the way up to commercialization.

Focus Areas
  • API Development
  • Formulation Development
  • Analytical Development
  • Regulatory Affairs
  • Intellectual Property Management
  • Project Management
  • Quality Assurance
  • Clinical Trials and Research

 

 


Notice: Undefined variable: id in /var/www/vhosts/fresenius-kabi-oncology.com/httpdocs/inc/inc.right.php on line 110
© All Copyright Reserved | Fresenius Kabi Oncology Limited 2012
This site is best viewed with a resolution of 1024x768 (or higher) and supports Microsoft Internet Explorer 8.0+ and Firefox 3.0+